Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...
A younger generation is embracing the nostalgic fitness craze. A younger generation is embracing the nostalgic fitness craze. Credit...By Dri.ster7/tiktok Supported by By Chloe W. Shakin Audri ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Bo French, a hard-liner known for wild social media posts, is seeking a bigger megaphone. Big oil companies, and top officials like Greg Abbott, want to stop him. By Lauren McGaughy Reporting from ...
For some oilmen, there’s only one thing they need to know about Bo French: He isn’t Jim Wright, the Railroad Commission’s incumbent chairman and French’s competition in a Republican primary runoff ...
Bo Erickson is a White House reporter based in Washington, DC. He focuses on the Trump administration’s domestic, political, and cultural agenda, as well as daily news throughout the world. Previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results